Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Omerosomeros.com · Low evidenceOmeros is a biopharmaceutical company focused on developing next-generation therapeutics to transform patient care across a range of diseases. The company targets both ultra-orphan and large-market indications with a data-driven approach to create life-saving therapies and improve patient outcomes.
Parse Score